Home > Press Releases

Press Releases (Page 16)

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum, which takes place March 22-23, 2022. Ron Rocca, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in a virtual fireside chat on... ❯❯❯

OnKure Therapeutics to Present Late-Breaking Preclinical Data on OKI-179 at the AACR Annual Meeting 2022

BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) -- OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today announced that preclinical data demonstrating synergy between OKI-179, the Company’s oral Class I histone deacetylase (HDAC) inhibitor, and the MEK inhibitor, binimetinib, in NRAS melanoma models has been accepted for presentation at the... ❯❯❯

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2021 after the market close on Tuesday, March 22, 2022. Ron Rocca, Exagen’s President and Chief Executive Officer, Kamal Adawi, Chief Financial Officer, and Mark Hazeltine, Chief Operating Officer, will host a conference call to... ❯❯❯

Amedisys to Present at Multiple Healthcare Conferences in March

BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris Gerard, President and Chief Operating Officer, and Scott Ginn, Executive Vice President and Chief Financial Officer, will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 16 at 10:40 a.m. EST and at the Barclays... ❯❯❯

SeaSpine® Announces New Senior Leadership Team Appointments

CARLSBAD, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the elevation of Dr. Frank Vizesi to Chief Scientific Officer and Shaeffer Bannigan to Vice President, Product Development, Spinal Implants. With his promotion, Mr. Bannigan joins the SeaSpine Senior Leadership Team. ... ❯❯❯

RAMSAY SANTE : Half-year Financial Report as at end of December 2021 disposal

  Paris, February 24, 2022    RAMSAY SANTE Half-year Financial Report as at end of December 2021 disposal   This document is available on RAMSAY SANTE Internet site : http://www.ramsaygds.com About Ramsay Santé : After the successfull acquisition of Capio AB Group in 2018, Ramsay Santé is becoming one of the leaders of the hospitalisation and primary care in Europe with 36 000 employees and 8 600 practitioners serving 7... ❯❯❯

Ramsay Sante : public offer to acquire GHP Specialty Care - March 7 2022

Press releaseParis, 7 March, 2022 Ramsay Santé takes further steps towards its development in the Nordics and announces a recommended public offer to acquire GHP Specialty Care Ramsay Santé, through its Swedish subsidiary Capio Group Services AB (“Capio”), has announced a recommended public offer to acquire GHP Specialty Care AB (“GHP”), a Swedish specialty healthcare provider listed on Nasdaq Stockholm. The proposed... ❯❯❯

Core One Labs’ Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations

VANCOUVER, British Columbia, March 04, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”), has entered into an agreement with the Universidad Complutense de Madrid (“Universidad Complutense”), officially commencing neurogenesis stimulation and modeling... ❯❯❯

Shineco, Inc. Announces New Website Launch

BEIJING, March 03, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced the launch of its redesigned website at www.biosisi.com. The redesigned website reflects the recent developments in the Company's growth trajectory, as the Company has entered the life science industry. It further... ❯❯❯

CorVel’s Critical Incident Stress Debriefing Program Offers Proactive Approach to Mental Health for Employees After Experiencing Traumatic Events

Presentation at PARMA highlights program benefits for public agencies and their employeesIRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, presented its Critical Incident Stress Debriefing program, highlighting positive outcomes with the City of Beverly Hills, at the annual Public Agency Risk Management Association (PARMA) meeting on March 1, 2022,... ❯❯❯